Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Orion

67.45 EUR

+1.05 %

14,337 following

ORNBV

NASDAQ Helsinki

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarterly estimates

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Orion

Q1/25Q2/25Q3/25Q4/252025Q1/26eQ2/26eQ3/26eQ4/26e
Revenue354.9416.5422.8695.31,889.5403.7477.3484.2575.9
EBITDA91.5118.6135.2344.2689.5119.9155.9176.8242.1
EBIT (adj.)77.9104.6121.0328.1631.6107.1143.0163.9229.2
EBIT77.9104.6121.0328.1631.6107.1143.0163.9229.2
EBIT-% (adj.)21.9 %25.1 %28.6 %47.2 %33.4 %26.5 %30.0 %33.9 %39.8 %
EBIT-%21.9 %25.1 %28.6 %47.2 %33.4 %26.5 %30.0 %33.9 %39.8 %
Profit before taxes76.9103.4120.4327.0627.7106.1142.0162.9228.2
Net income61.382.596.0260.4500.283.6112.0128.5180.1
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.